23.6
Eton Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
20.0
FY23:
26.8
FY24:
41.0
FY25:
60.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.86
FY22:
5.03
FY23:
4.90
FY24:
35.1
FY25:
31.5
Total assets
Change from FY21 to FY25
millions USD
FY21:
27.5
FY22:
25.0
FY23:
31.7
FY24:
76.1
FY25:
92.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.56
FY22:
6.46
FY23:
16.2
FY24:
19.9
FY25:
38.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.28
FY22:
5.49
FY23:
0.02
FY24:
31.7
FY25:
27.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
17.6
FY22:
13.1
FY23:
15.5
FY24:
24.4
FY25:
26.2
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
27.5
FY22:
25.0
FY23:
31.7
FY24:
76.1
FY25:
92.1
All amounts in millions USD